Entasis Therapeutics

YTD

ALL

Why Robinhood?

You can watch ETTX and buy or sell other stocks, ETFs, and their options commission-free!

About ETTX

Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections.

CEO

Manoussos Perros, PhD

CEOManoussos Perros, PhD

Employees

—

Employees—

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2015

Founded2015

Employees

—

Employees—

ETTX Key Statistics

Market cap

104.80M

Market cap104.80M

Price-Earnings ratio

-1.95

Price-Earnings ratio-1.95

Dividend yield

—

Dividend yield—

Average volume

86.16K

Average volume86.16K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$3.88

52 Week high$3.88

52 Week low

$1.40

52 Week low$1.40

People also own

Based on the portfolios of people who own ETTX. This list is generated using Robinhood data, and it’s not a recommendation.